Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Li Chow

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|June 14, 2025
Anti-HMGCR myopathy: observed ethnic differences in disease and disease outcomes in New ZealandHamish Anderson, Ke Li Chow, John O'Donnell
International Journal of Cardiology|April 8, 2022
Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New ZealandKe Li Chow, John Liston O'Donnell, Ian Crozier
Internal Medicine Journal|June 12, 2019
Recurrent membranoproliferative glomerulonephritis in a renal transplant secondary to monoclonal gammopathy of renal significance successfully treated with bortezomibKe Li Chow, John Kanellis, Sukhpal Dayan, et al.
Pathology|November 18, 2022
Subtyping anti-infliximab antibodies by the homogenous mobility shift assay (HMSA): potential utility in a pharmacokinetic case studyKe Li Chow, Paula Elizabeth Keating, John Liston O'Donnell
Rheumatology (Oxford, England)|May 25, 2024
Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared with European populations in Aotearoa/New ZealandKe Li Chow, Paula Elizabeth Keating, John Liston O'Donnell
Pathology|July 3, 2021
HMGCR autoantibody testing: two tiers requiredKe Li Chow, Paula Elizabeth Keating, Myfanwy Bailey Spellerberg, et al.
Seminars in Arthritis and Rheumatism|July 30, 2024
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New ZealandKe Li Chow, Paula Elizabeth Keating, Kamal Solanki, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 13, 2026
Vocal Cord Dysfunction / Inducible Laryngeal Obstruction (VCD/ILO) as a mimic of anaphylaxis: A retrospective cohort studyPaul Satouris, Georgina Hallam, Ke Li Chow, et al.
Frontiers in Immunology|March 18, 2026
Risk factors and surrogate indicators for cardiovascular disease are prevalent in Common Variable Immunodeficiency and associate with inflammatory phenotypeAidan Jia Sheng Yu, Fernando Moreira, Andrew Symes, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|June 14, 2025
Anti-HMGCR myopathy: observed ethnic differences in disease and disease outcomes in New ZealandHamish Anderson, Ke Li Chow, John O'Donnell
International Journal of Cardiology|April 8, 2022
Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New ZealandKe Li Chow, John Liston O'Donnell, Ian Crozier
Internal Medicine Journal|June 12, 2019
Recurrent membranoproliferative glomerulonephritis in a renal transplant secondary to monoclonal gammopathy of renal significance successfully treated with bortezomibKe Li Chow, John Kanellis, Sukhpal Dayan, et al.
Pathology|November 18, 2022
Subtyping anti-infliximab antibodies by the homogenous mobility shift assay (HMSA): potential utility in a pharmacokinetic case studyKe Li Chow, Paula Elizabeth Keating, John Liston O'Donnell
Rheumatology (Oxford, England)|May 25, 2024
Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared with European populations in Aotearoa/New ZealandKe Li Chow, Paula Elizabeth Keating, John Liston O'Donnell
Pathology|July 3, 2021
HMGCR autoantibody testing: two tiers requiredKe Li Chow, Paula Elizabeth Keating, Myfanwy Bailey Spellerberg, et al.
Seminars in Arthritis and Rheumatism|July 30, 2024
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New ZealandKe Li Chow, Paula Elizabeth Keating, Kamal Solanki, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 13, 2026
Vocal Cord Dysfunction / Inducible Laryngeal Obstruction (VCD/ILO) as a mimic of anaphylaxis: A retrospective cohort studyPaul Satouris, Georgina Hallam, Ke Li Chow, et al.
Frontiers in Immunology|March 18, 2026
Risk factors and surrogate indicators for cardiovascular disease are prevalent in Common Variable Immunodeficiency and associate with inflammatory phenotypeAidan Jia Sheng Yu, Fernando Moreira, Andrew Symes, et al.
Pageof 1